Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer

被引:23
|
作者
Yang, Guoliang [1 ]
Bondaruk, Jolanta [1 ]
Cogdell, David [1 ]
Wang, Ziqiao [2 ]
Lee, Sangkyou [1 ]
Lee, June Goo [1 ]
Zhang, Shizhen [1 ]
Choi, Woonyoung [3 ]
Wang, Yan [1 ]
Liang, Yu [1 ]
Wang, Gang [1 ]
Wang, Ying [2 ]
Yao, Hui [4 ]
Dadhania, Vipulkumar [1 ]
Gao, Jianjun [5 ]
Logothetis, Christopher [5 ]
Siefker-Radtke, Arlene [5 ]
Kamat, Ashish [6 ]
Dinney, Colin [6 ]
Theodorescu, Dan [7 ]
Kimmel, Marek [8 ]
Wei, Peng [2 ]
Guo, Charles C. [1 ]
Weinstein, John N. [4 ]
McConkey, David J. [3 ]
Czerniak, Bogdan [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Johns Hopkins Univ, Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[7] Cedars Sinai, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[8] Rice Univ, Dept Stat, Houston, TX 77251 USA
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; INFILTRATING IMMUNE CELLS; MOLECULAR CLASSIFICATION; LUMINAL SUBTYPES; CARCINOMA; BREAST; EXPRESSION; BASAL; IDENTIFICATION; DYSREGULATION;
D O I
10.1016/j.isci.2020.101201
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We report a comprehensive molecular analysis of 34 cases of small cell carcinoma (SCC) and 84 cases of conventional urothelial carcinoma (UC), with The Cancer GenomeAtlas cohort of 408 conventional UCbladder cancers used as the reference. SCCs showed mutational landscapes characterized by nearly uniforminactivation of TP53 and were dominated by Sanger mutation signature 3 associated with loss of BRCA1/2 function. SCCs were characterized by downregulation of luminal and basal markers and were referred to as double-negative. Transcriptome analyses indicated that SCCs displayed lineage plasticity driven by a urothelial-to-neural phenotypic switch with a dysregulated epithelial-to-mesenchymal transition network. SCCs were depleted of immune cells, and expressed high levels of the immune checkpoint receptor, adenosine receptor A2A(ADORA2A), which is a potent inhibitor o fimmune infiltration. Our observations have important implications for the prognostication and development of more effective therapies for this lethal bladder cancer variant.
引用
收藏
页数:35
相关论文
共 50 条
  • [31] Bladder cancer patient-derived organoids to decipher cellular plasticity and cancer progression
    Garioni, Michele
    Roma, Luca
    Mevel, Renaud
    Vlajnic, Tatjana
    Pueschel, Heike
    Iber, Dagmar
    Seifert, Hans-Helge
    Rentsch, Cyrill A.
    Bubendorf, Lukas
    Le Magnen, Clementine
    CANCER RESEARCH, 2022, 82 (12)
  • [32] Subtypes in small cell bladder cancer
    Stone, Louise
    NATURE REVIEWS UROLOGY, 2023, 20 (09) : 521 - 521
  • [33] Subtypes in small cell bladder cancer
    Louise Stone
    Nature Reviews Urology, 2023, 20 : 521 - 521
  • [34] Re: KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
    Siegel, Cary
    JOURNAL OF UROLOGY, 2024, 211 (02): : 331 - 332
  • [35] Clinical implications of epithelial cell plasticity in cancer progression
    Aparicio, Luis A.
    Blanco, Moises
    Castosa, Raquel
    Concha, Angel
    Valladares, Manuel
    Calvo, Lourdes
    Figueroa, Angelica
    CANCER LETTERS, 2015, 366 (01) : 1 - 10
  • [36] Stem Cell Plasticity and Niche Dynamics in Cancer Progression
    Picco, Noemi
    Gatenby, Robert A.
    Anderson, Alexander R. A.
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2017, 64 (03) : 528 - 537
  • [37] Defects in Muscarinic Receptor Cell Signaling in Bladder Urothelial Cancer Cell Lines
    Tully, Brian T.
    Li, Mingkai
    Sun, Yan
    Berkowitz, Jared
    Chai, Toby C.
    UROLOGY, 2009, 74 (02) : 467 - 473
  • [38] When urothelial differentiation pathways go wrong: Implications for bladder cancer development and progression
    DeGraff, David J.
    Cates, Justin M.
    Mauney, Joshua R.
    Clark, Peter E.
    Matusik, Robert J.
    Adam, Rosalyn M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (06) : 802 - 811
  • [39] AMBRA1 drives gastric cancer progression through regulation of tumor plasticity
    Ye, Liuqi
    Lin, Danlei
    Zhang, Wen
    Chen, Shiji
    Zhen, Yumiao
    Akkouche, Sara
    Liang, Xiaoxu
    Chong, Cheong-Meng
    Zhong, Hai-Jing
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [40] Lineage plasticity as a determinant of antibody-drug conjugate target expression in urothelial bladder cancer
    Luo, Jiaqian
    Gao, Sizhi P.
    Kuo, Fengshen
    Ozcan, Gamze Gokturk
    Basar, Merve
    Koll, Florestan
    Tallman, Jacob E.
    Alam, Syed M.
    Chu, Carissa E.
    Chen, Ziyu
    Pietzak, Eugene J.
    Iyer, Gopakumar
    Rosenberg, Jonathan E.
    Solit, David B.
    Al-Ahmadie, Hikmat
    CANCER RESEARCH, 2024, 84 (06)